When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Shares of Kura Oncology (NASDAQ: KURA) , a clinical-stage biopharmaceutical company , are down sharply in response to a clinical hold for the company's experimental leukemia treatment. The stock was down 15.6% as of 11:20 a.m. ET on Wednesday.
The Food and Drug Administration placed a partial clinical hold on a phase 1 trial with KO-539 after the death of a patient. The adverse event was potentially associated with differentiation syndrome (DS).